CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001489
NCT00001489N/ACompleted
CompareCT.gov

The Effect of Vigabatrin on Cerebral Blood Flow and Glucose Metabolism

National Institute of Neurological Disorders and Stroke (NINDS)·observational·Posted Dec 10, 2002·Updated Mar 4, 2008

In Brief

An observational study for Epilepsy and Epilepsy, Complex Partial. Completed, across 1 site.

Detailed Summary

This study is designed to test the effects of vigabatrin (gamma-vinyl-GABA) an experimental drug used for the treatment of epilepsy. The study will use positron emission tomography (PET scan) to detect areas of the brain receiving increased blood flow and using increased amounts of glucose. Increases in blood flow and glucose use are good indicators of brain activity. Researchers are interested in determining the effects of Vigabatrin on brain blood flow and glucose use.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEpilepsy, Epilepsy, Complex Partial
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 10, 2002
Enrollment StartOct 1, 1994
Study CompletionAug 1, 2000
TodayJul 2, 2026
Posted 23.6 years ago